HMGCR and liver cancer: In line with this, recent studies have shown that simvastatin, a potent HMGCR inhibitor, induces apoptosis and cell cycle arrest by activating AMPK and inhibiting the Signal Transducer and Activator of Transcription 3 (STAT3) axis, both in liver cancer cells and tumor xenografts (112, 113).